Nicotine is a small molecule that crosses the blood-brain barrier rapidly. Within 7-10 seconds of inhalation via vape or smoking, nicotine reaches the brain. It binds to nicotinic acetylcholine receptors (nAChRs), which are present throughout the central nervous system, peripheral nervous system, adrenal medulla, and many other tissues. nAChRs are pentameric ligand-gated ion channels – when nicotine binds, channels open, ions flow, and downstream signalling cascades activate. The specific effects depend on which nAChR subtypes are activated and where in the body.

Brain effects (within 7-10 seconds, lasting 30+ minutes): activates dopamine release in the ventral tegmental area and nucleus accumbens (reward, motivation, pleasure – “the buzz”); activates noradrenaline release (alertness, focus, vigilance); activates serotonin and beta-endorphins (mild mood elevation, pain relief). Brain imaging studies show acute increases in prefrontal cortex and thalamus activity. Long-term: chronic use upregulates nAChRs (tolerance), depletes baseline neurotransmitter reserves, and may impair cognition. In under-25s, nicotine affects developing brain circuits with potentially lasting effects on attention, memory and addiction vulnerability.

Cardiovascular effects: activates sympathetic nervous system causing adrenaline release. Heart rate increases +10-15 bpm. Blood pressure increases +7-10 mmHg systolic. Coronary and skin blood vessels constrict (reduced blood flow to extremities and heart muscle). Endothelial dysfunction over time (reduced nitric oxide production). Pro-thrombotic state (slightly increased clotting). Long-term: may contribute to atherosclerosis (hardening of arteries) per American Heart Association. Endocrine effects: triggers cortisol release (stress hormone); reduces insulin sensitivity (mild blood sugar elevation); affects thyroid hormone signalling; in some studies affects gonadal hormones (sex hormones). Gastrointestinal: increases gut motility (some users get nausea or diarrhoea); diuretic effect (increased urination). Respiratory: bronchodilation (acute, mild); reduced cough reflex; effects on mucociliary clearance.

The brain effects: why nicotine is so reinforcing

The brain effects of nicotine explain its addiction potential. The key target: dopamine release in the nucleus accumbens, the brain’s primary reward circuit. This circuit evolved to reinforce survival behaviours (eating, drinking, sex) and is hijacked by addictive drugs. Nicotine activates dopamine release via two pathways. Pathway 1: direct activation of alpha-4-beta-2 nAChRs on dopamine neurons in the ventral tegmental area, causing dopamine release in target regions. Pathway 2: activation of alpha-7 nAChRs on glutamate terminals, increasing glutamate release which further drives dopamine neuron firing. The combined effect: dopamine spikes in the nucleus accumbens within seconds of inhalation, producing the “buzz.” The brain interprets this as a learning signal: “do that again.” Over repeated use, the brain forms associative memories linking context (vape device, location, time, mood) to dopamine reward. These memories drive future use. Chronic use produces three brain adaptations. First, receptor upregulation: nAChRs multiply, requiring more nicotine for same effect (tolerance). Second, baseline dopamine drops: the brain “expects” nicotine and produces less dopamine without it (withdrawal-cycling). Third, prefrontal cortex changes: executive control over urges weakens. These adaptations make cessation difficult and explain why withdrawal lasts weeks to months. UK NHS Stop Smoking pathways address all three via combination NRT (smooths receptor function), behavioural support (rebuilds prefrontal control), and time (allows brain to recover baseline).

The cardiovascular effects: from acute spike to chronic disease

Acute effects (per session): heart rate +10-15 bpm, blood pressure +7-10 mmHg systolic, vasoconstriction in coronary arteries and peripheral vessels, increased cardiac contractility. Mechanism: nicotine triggers adrenaline (epinephrine) release from the adrenal medulla via nAChR activation. Adrenaline circulates to the heart and blood vessels, producing classic “fight or flight” cardiovascular response. The effects persist 30-60 minutes per nicotine session, with multiple sessions daily creating sustained sympathetic load. Chronic effects (over years): endothelial dysfunction – the inner lining of blood vessels makes less nitric oxide, reducing their ability to dilate appropriately. Pro-thrombotic state – blood platelets become slightly more sticky. Inflammatory activation – low-grade inflammation in vessel walls. These changes contribute to atherosclerosis (hardening and narrowing of arteries) over years. Per the 2015 review “Harmful effects of nicotine”: “the mechanism by which nicotine affects the cardiovascular system involves endothelial dysfunction by reducing nitric oxide production, pro-thrombotic conditions, and activating inflammatory routes.” For UK adults with existing heart disease: acute nicotine effects can trigger angina or arrhythmias. Discuss with cardiologist. For UK adults without heart disease: cardiovascular harm from nicotine alone (without combustion) is modest. UK British Heart Foundation: for current smokers, switching to vape substantially reduces cardiovascular risk despite continued nicotine exposure.

Effects on other body systems: less famous but real

Five additional system effects often overlooked. Endocrine: nicotine activates the hypothalamic-pituitary-adrenal axis, increasing cortisol. Chronic users may have elevated baseline cortisol contributing to insulin resistance, weight gain (especially abdominal), and mood effects. Also affects gonadal hormones (testosterone, oestrogen) in complex ways. Gastrointestinal: nicotine increases gut motility (faster transit time), can cause nausea or diarrhoea in new users, increases gastric acid secretion (worsens reflux/GERD). Has historical interest as ulcerative colitis treatment (mixed evidence). Diuretic effects (increased urination) via vasopressin suppression. Reproductive: harms fetal development during pregnancy (low birth weight, premature birth, SIDS risk). Reduces fertility in both men (sperm quality, count) and women (egg quality, ovulation). Skin: vasoconstriction reduces skin blood flow contributing to premature ageing, slower wound healing. Often-cited but harder to attribute solely to nicotine vs other smoking components. Immune system: chronic nicotine has complex effects, some studies showing reduced immune responses. Slight elevation in respiratory infection rates in chronic users per US research. Bone: nicotine reduces bone density and increases osteoporosis risk over years. Eyes: increased risk of macular degeneration and cataracts (mostly smoking-related, contribution of nicotine alone unclear). For UK adults: these system effects are typically modest individually but add up cumulatively over years of chronic use. Cessation reverses most of them over months to years.

For UK adults wanting to understand nicotine’s body effects, the five system framework below summarises peer-reviewed research.

For UK adults wanting to understand their personal nicotine exposure effects, NHS health checks (free, every 5 years from age 40 to 74) assess cardiovascular risk including effects of nicotine use. Honest disclosure of vape and smoking history is important for accurate assessment. Most nicotine effects reverse with cessation. For current smokers, switching to vape via NHS Stop Smoking substantially reduces overall harm even if nicotine effects persist. Our Omagh and Strabane teams can advise on stepdown pathways for UK adults planning cessation.